Document:

Garden State Securities Inc.

 

June 1,2011

 

Radient Pharmaceuticals Corporation

2492 Walnut
Avenue

Suite 100

Tustin, CA 92780-6952

Attn: Douglas C. MacLellan, CEO

 

Re: Advisory Services

 

Dear Mr. MacLellan:

 

This letter
confirms the engagement of Garden State Securities Inc., a FINRA member firm (“GSS”), as a non-exclusive financial advisor
to Radient Pharmaceuticals Corporation and its subsidiaries and affiliates (together, referred to as the “Company”) for
a period of 7 months commencing upon the date of your acceptance of this letter. In this regard, the parties agree to the following
terms and conditions:

 

1.          Engagement.
The Company hereby engages and retains GSS as a non-exclusive financial advisor for and on behalf of the Company to perform the
Services as defined in Section 2. GSS hereby accepts this engagement on the terms and conditions set forth in this Agreement.

 

2.          Services.
In connection with its engagement pursuant to this Agreement, GSS agrees to perform the following services for the Company:

 

A.           Advisory
Services. As requested from time to time by the Company, GSS shall provide financial advisory services to the Company pertaining
to the Company's business affairs. Without limiting the foregoing, GSS will assist the Company in developing, studying and evaluating
a financing plan, strategic and financial alternatives, and merger and acquisition proposals and will assist in negotiations and
discussions pertaining thereto. Additionally, GSS will assist the Company in preparing an offering document or presentation materials
describing the Company, its operations, its historical performance and future prospects.

 

B.           GSS
agrees to use its best efforts to make itself available to the Company’s officers, at such mutually agreed upon place and time
during, normal business hours for reasonable periods of time for the purpose of advising and assisting the Company in preparing
reports, summaries, corporate and/or transaction profiles, due diligence packages and/or other material and documentation as shall
be necessary, in the opinion of GSS. Such availability will be subject to reasonable advance notice and mutually convenient scheduling.
In addition, GSS shall make its Investment Banking personnel available for telephone conferences with the Company's principal financial
sales and/or operating officers during normal business hours upon reasonable advance notice and mutually agreed upon dates and
times to assist with, and evaluate proposals.

 

    	 

    	 

    

 

3.          Compensation.
As compensation for the services rendered by GSS to the Company pursuant to this Agreement and in addition to the expense allowance
set forth in Section 4 (“Expenses”) below, the Company shall pay to GSS as set forth below:

 

Advisory
Services: Upon execution of this Agreement, the Company shall issue to GSS (i) 200,000 vested restricted shares (the “Shares”)
of the Company’s common stock upon execution of this Agreement and (ii) 100,000 vested Shares of the Company's Common Stock on
the 1st day of each consecutive proceeding 30 day period from the date of the execution of this Agreement for 6 consecutive
30 day periods (6 months), subject to termination as set forth in Section 10. The Shares shall be issued in the name of GSS by
delivery by GSS of instructions to the Company providing for the names of designees who are employees and/or affiliates of GSS.
The Company shall deliver to GSS and the Company's transfer agent, legal opinion letters for GSS and for each designee, at the
time that the shares are eligible to be sold pursuant to SEC Rule 144, upon GSS's request.

 

4.          Expenses.
In addition to the compensation in Section 4, “Compensation” above, The Company agrees to reimburse GSS, upon request
made from time to time, for its reasonable out-of-pocket expenses incurred by GSS in connection with its activities under this
Agreement; provided, however, GSS shall not incur any expense in excess of $500 without the prior written consent of the Company.
These expenses include but are not limited to long distance phone charges, airfare, hotel lodging and meals, transportation, outside
consultants, printing, and overnight express mail incurred by GSS in fulfilling its duties under this Agreement.

 

5.          Confidentiality
and Non- Disclosure. The Company will not provide GSS or any GSS affiliate with any material non-public information without
prior written notice in which GSS will only accept receipt of such material non-public information after the signing of a separate
non-disclosure agreement between the Company and GSS. The Company is prepared to make available to GSS upon GSS’s request,
certain information concerning the business, financial condition, operations, assets and liabilities of the Company in connection
with the performance of its duties hereunder. As a condition to such information being furnished to GSS and its employees or agents,
GSS agrees to treat any information concerning the Company (whether prepared by the Company, its advisors, investors or otherwise
and irrespective of the form of communication) which is furnished to GSS or to its employees or agents now or in the future by
or on behalf of the Company (herein collectively referred to as the “Evaluation Material”) in accordance with
the provisions of this Agreement, and to take or abstain from taking certain other actions hereinafter set forth. The term “Evaluation
Material” also shall be deemed to include all notes, analyses, compilations, studies, interpretations or other documents
prepared by GSS, its employees or agents which contain, reflect or are based upon, in whole or in part, the information furnished
to GSS, its employees or agents pursuant hereto. The term “Evaluation Material” does not include information
which (i) is or becomes generally available to the public other than as a result of a disclosure by GSS, its employees or agents,
or (ii) becomes available to GSS on a non-confidential basis from a source other than the Company (including without limitation
any of the Company's directors, officers, employees or agents), or any of its attorneys, accountants, investors, consultants,
bankers and financial advisors (collectively, the “Representatives”), provided that such source is not bound
by a confidentiality agreement with or other contractual, legal or fiduciary obligation of confidentiality to the Company or any
other party with respect to such information.

 

    	 

    	 

    

 

GSS hereby
agrees that GSS, its employees and agents shall use the Evaluation Material solely for the purposes contemplated by this Agreement,
that the Evaluation Material will be kept confidential and that GSS, its employees and agents will not disclose any of the Evaluation
Material in any manner whatsoever; provided, however, that GSS may make any disclosure of such information to which
the Company give its prior written consent.

 

6.          Indemnification.
The Company agrees to indemnify GSS and its affiliates and their respective directors, officers, employees, agents and controlling
persons (each such person being an “Indemnified Party”) from and against any and all losses, claims, damages and liabilities,
joint or several, related to or arising out of the engagement of GSS pursuant to, and the performance by GSS of the services contemplated
by, this Agreement and will reimburse any Indemnified party for all expenses (including fees and costs of counsel) as they are
incurred in connection with the investigation of, preparation for or defense of any pending or threatened claim or any action or
proceeding arising therefrom, whether or not such Indemnified Party is a party and whether or not such claim, action or proceeding
is initiated or brought by or on behalf of the Company; provided, however, that the Company will not be liable for any indemnification
or contribution hereunder to the extent that any losses, claims, damages and liabilities arise from or as a result of any grossly
negligent conduct or willful malfeasance by an Indemnified Party. If the indemnification of an Indemnified Party provided for in
this Agreement is for any reason held unenforceable, the Company agrees to contribute to the losses, claims, damages and liabilities
for which such indemnification is held unenforceable is such proportion as is appropriate to reflect the relative benefits to the
Company, on the one hand, and GSS, on the other hand; provided, however, that in no event shall the Indemnified Parties be required
to contribute an aggregate amount in excess of the aggregate fees actually paid to GSS under this Agreement. The Company agrees
that it will not settle, compromise or consent to the entry of any judgment in any pending or threatened claim, action or proceeding
in respect of which indemnification could be sought under the indemnification provision of this Agreement (whether or not GSS or
any other Indemnified Party is an actual or potential party to such claim, action or proceeding), unless such settlement, compromise
or consent includes an unconditional release of each Indemnified Party from all liability arising out of such claim, action or
proceeding.

 

7.          Independent
Contractor. The Company acknowledges that GSS has been retained to act solely as a financial advisor to the Company. In such
capacity, GSS shall act as an independent contractor, and any duties of GSS arising out of its engagement pursuant to this Agreement
shall be owed solely to the Company. GSS shall be responsible for the payment of all federal, state and local taxes which may be
payable in connection with the receipt of compensation hereunder.

 

8.          NYSE
Amex Approval. Consultant acknowledges that the issuance of the Shares is subject to the prior approval of the NYSE Amex (the
“Amex Approval”), without which, the Shares will not be issued. In the event that the Company is not listed on the AMEX
then any and all shares do or owned will be issued by the Company.

 

    	 

    	 

    

 

9.          Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the State of New York. Each of GSS and
the Company agree that any dispute or controversy arising under or in connection with this Agreement shall be settled exclusively
by binding arbitration. The arbitration will be conducted in accordance with the rules of the American Arbitration Association
(the “AAA”) then in effect (“AAA Rules”) and the procedures in this document. In the event of a conflict, the
provisions of this document will control. The arbitration will be conducted by a panel of three arbitrators, one chosen by each
party to this Agreement and the third by agreement of the parties; failing agreement within 30 days of commencement of the arbitration
proceeding, the AAA will appoint the third arbitrator.. Any issue concerning the extent to which any dispute is subject to arbitration,
or concerning the applicability, interpretation, or enforceability of these procedures, including any contention that all or part
of these procedures are invalid or unenforceable, shall be governed by the Federal Arbitration Act and resolved by the arbitrator.
Unless provided otherwise in this Agreement, the arbitrators may not award damages inconsistent with the Agreement or punitive
damages or any other damages not measured by the prevailing party's actual damages, and the parties expressly waive their right
to obtain such damages in arbitration. In no event, even if any other portion of these provisions is held to be invalid or unenforceable,
shall the arbitrators have power to make an award or impose a remedy that could not be made or imposed by a court deciding the
matter in the same jurisdiction..

 

10.         Term
and Termination. This Agreement shall be effective upon its execution and shall remain in effect for 7 months from the date
of execution by the Company. Either the Company or GSS may terminate GSS’s engagement and responsibilities hereunder with
a 10-day advance written notice at any time after 90 days from the date of the execution of this Agreement. However, no termination
of this Agreement shall in any way effect the right of GSS to receive the Shares for the services rendered up to the date of termination..
In addition, Section 6, “Indemnification,” Section 7, “Independent Contractor,” and Section 9, “Governing
Law” shall survive any termination of this Agreement.

 

11.         Entire
Agreement. This Agreement contains the entire Agreement and understanding between the parties with respect to its subject matter
and supersedes all prior discussion, agreements and understandings between them with respect thereto. This Agreement may not be
modified except in a writing signed by the parties.

 

12.         Assignment.
Neither this Agreement nor the rights of either party hereunder shall be assigned by either party without the prior written consent
of the other party.

 

13.         Counterparts.
This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together
shall constitute one and the same instrument.

 

14.         Press
Releases/Public Announcements. Neither party shall issue any press release or public announcement of this Agreement or the
terms hereof without the prior consent of the other party; provided, however, the Company may make filings under applicable federal
and state securities laws as required under applicable law but shall provide GSS with a reasonable opportunity to review and comments
upon any proposed filing.

 

    	 

    	 

    

 

	 	Sincerely,
	 	 
	 	Garden State Securities Inc.
	 	 
	 	By:	/s/ Ernest Pellegrino
	 	Name: Ernest Pellegrino
	Agreed and Accepted:	Title: Director of Corporate Finance

 

	Date: Junel, 2011	 
	 	 
	By:	/s/ Douglas, C. MacLellan	 
	Name: Mr. Douglas, C. MacLellan	 
	Title: CEO, Radient Pharmaceutical Corp.AMENDMENT TO ADVISORY AGREEMENT

 

THIS AMENDMENT to the Advisory
Agreement entered into on August 1, 2010 (“Original Agreement”) whereby RADIENT PHARMACEUTICALS CORPORATION,
a Delaware corporation having its principal place of business at 2492 Walnut Avenue, Suite 100, Tustin, CA 92780-7039,(“The
Company”) retained Garden State Securities Inc., a FINRA member firm (“GSS”), to render services
as defined in the Original Agreement, is hereby made in order to amend Section 3 of the Original Agreement with regard
to GSS's Compensation.

 

In consideration for the mutual
premises herein, the sufficiency of which is hereby acknowledged, the parties hereto agree to the following amendment to Section
3:

 

The Company shall issue an
additional 75,000,000 common shares of the Company, in addition to the Compensation previously agreed to in the Original Agreement.

 

(i) 50% of these shares shall
be issued immediately and shall vest the later of either 6 months after the date of issuance or such date that the Company is current
in their public filings and the shares can be sold in accordance with Rule 144 and (ii) 50% shall be issued in equal installments
over the next twelve (12) months and shall vest the later of either 6 months after the date of issuance or such date tthat he Company
is current in their public filings and the shares can be sold in accordance with Rule 144.

 

The Company shall immediately
issue the shares due and owing from the Original Agreement and these shares shall vest on January 3,2012.

 

The shares described above
shall be subject to the anticipated reverse split(s), will not be registered for resale under the Securities Act and shall only
be available for resale SEC pursuant to Rule 144 (6-month hold).

 

By signing this Amendment,
the Agreement shall hereby be extended for 12 months beginning November 1, 2011 through October 31,2012.

 

Except as otherwise set forth
herein, all terms and conditions in the Original Agreement shall remain in full force and effect and this Amendment shall not change
or modify the Original Agreement other than described above.

 

    	 

    	 

    

 

The parties have caused this
Agreement to be executed by their duly authorized representatives as of the date written above.

 

Dated: November 21, 2011

Addendum terms accepted by:

RADIENT PHARMACEUTICALS CORPORATION

 

	By:	 /s/ Douglas C. MacLellan
	Name: Douglas C. MacLellan
	Title: Chief Executive Officer

 

GARDEN STATE SECURITIES INC.

	By:	 /s/
    Ernest Pellegrino
	Name: Ernest Pellegrino
	Title: Director of Corporate Finance

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00199-of-00352.parquet"}]]